Top advances of the year: Hepatobiliary cancers.

Kelley L Coffman-D'Annibale,Tim F Greten

Cancer（2023）

引用 1|浏览8

暂无评分

摘要

This commentary reviews top advances in hepatobiliary cancer research in 2021-2022, focusing on leveraging immunotherapeutics in combination with other therapies earlier in the disease course and targeted to patient's individualized biomarkers that may predict response or resistance to checkpoint inhibitors.

查看译文

关键词

biliary tract cancer,biomarker studies,checkpoint inhibitors,cholangiocarcinoma,correlative studies,hepatocellular carcinoma,immunotherapy,liver cancer,neoadjuvant therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要